Abstract
increasing number of patients suffered new congestive heart failure (CHF) and aggravated CHF after pacing
therapy. We used blood B type nutriuretic peptide (BNP) to predict the occurrence of CHF in patients with different
types of pacemakers. To assess single N-terminal brain nutriuretic peptide (NT-pro BNP) as a predictor
tool for ventricular dysfunction in different cardiac pacing mode.
Methods: Out of 480 consecutive patients with pacemaker more than 6 months, 79 patients with average age
of 65±13, and more than 90% ventricular pacing participated in the present study. Those with CHF prior to
pacemaker insertion were excluded. The patients underwent medical history and examination, echocardiography
(M-mode, Doppler, and Tissue imaging) and blood sampling for pro-BNP. Twenty five, 12, and 42 patients
had Dual chamber (DDDR), single chamber pacing with dual chamber sensing ( VDDR), and Single chamber
(VVIR) pacemakers respectively
Results: Single pro-BNP level in patient with DDDR and VDDR pacing was lower than in those with VVIR
pacing (P< 0.0001) but in Echocardiography left ventricular (LV) dysfunction was not lower in DDDR than
VDDR and VVIR pacing patients (P= 0.190).
Conclusion: Single level of pro-BNP is lower in double chamber pacing in comparison with single chamber
pacing. Therefore, it seems that dual chamber pacing causes less LV dysfunction.
Keywords
NT- pro B-type natriuretic peptide (BNP) tissue Doppler pacing
Fulltext
The full text is available in PDF.
References
-
1.
The references are available in PDF.